Drug Database
Back to search

Poland· PL-100053016

Pilocarpinum WZF 2%

A pilocarpine product containing pilocarpini hydrochloridum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC S01EB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPilocarpinum WZF 2%ATCS01EB01REGISTER NO.PL-100053016PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pilocarpini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pilocarpine is registered in 10 of 19 countries.

Countries holding a registration under ATC S01EB01 (pilocarpine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search pilocarpine products by name

Pilocarpine · ATC S01EB01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pilocarpini hydrochloridum
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
S01EB01
ATC class
Pilocarpine
Defined daily dose
0.285 Lamelle
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990237517
  • gtin
    05909990237524

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

50 interactions on record for pilocarpine.

Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pilocarpine against other medicinesHow interaction checks work

Pilocarpine · interactions on record

50 records

  • 50 moderate

Most severe, free to view

  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • MepenzolateA03AB12moderate
  • TrospiumA03AB20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pilocarpine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pilocarpine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Pilocarpin Agepha, Pilocarpin Puroptal
  • Belgium · Isopto
  • Bulgaria · Пилокарпин Вижън
  • Cyprus · Prothenol
  • Germany · Pilocarpinhydrochlorid Bay Pharma, Pilocarpinhydrochlorid Smartpractice Europe
  • Spain · Colircusí, Pilocarpina Apotheke
  • Finland · Isopto Carpine, Salagen
  • France · Isopto, Pilocarpine Faure
  • United Kingdom (Northern Ireland) · Pilocarpine Hydrochloride, Pilocarpine Hydrochloride Blumont Pharma
  • Greece · Cidren, Dryboka
  • Hungary · Salagen
  • Ireland · Minims
  • Italy · Dropilton, Pilocarpina Farmigea
  • Luxembourg · Isopto, Spersacapin
  • Netherlands · Minims Pilocarpinenitraat Bausch + Lomb Ireland Limited, Salagen
  • Norway · Minims
  • Portugal · Salagen
  • Sweden · Pilokarpin Karo Pharma, Salagen
  • Slovenia · Salagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5fe32eae-06c6-471d-8934-4e891913c1da
GET /v1/drugs/5fe32eae-06c6-471d-8934-4e891913c1da?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "20 mg/ml",
  "packaging": "05909990237517 ¦ Rp ¦ Skasowane ¦ 7960\n1 butelka 5 ml\nRp ¦ Skasowane ¦ 7961\n1 fl. 10 ml\n05909990237524 ¦ Rp ¦ 47366\n2 butelki 5 ml",
  "substance": "Pilocarpini hydrochloridum 20 mg",
  "common_name": "Pilocarpini hydrochloridum",
  "pl_product_id": "100053016",
  "pozwolenie_nr": "02375",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about pilocarpine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console